ChainCatcher report: DeSci project NanoVita has successfully completed a $10 million FDV seed round, led by Cryptogram Venture (CGV), UNIVERSE-DIMENSIONAL SPACE PTE. LTD. (Singapore), Candaq Fintech Group, and Susie Ventures (BVI). NanoVita is a decentralized science (DeSci) protocol integrating nanotechnology, AI-driven biological intelligence, and real-world health data to build an open and transparent infrastructure for health research. The completion of this funding round marks the acceleration of NanoVita’s initiatives in nanotechnology, AI-driven biological intelligence, and blockchain-based health. The project will further advance the development of a decentralized health research ecosystem, leveraging blockchain technology to restructure and enable open sharing of health data value.
DeSci Project NanoVita Completes $10M Seed Round with CGV and Others
ChaincatcherShare
Summary
The DeSci project NanoVita announced a $10 million FDV seed round, marking a major funding milestone in the blockchain health sector. The round was led by CGV, UNIVERSE-DIMENSIONAL SPACE PTE. LTD., Candaq Fintech Group, and Susie Ventures (BVI). NanoVita integrates nanotechnology, AI bio-intelligence, and real-world health data to build a decentralized health research infrastructure. This funding announcement signals a new phase of expansion for blockchain health and decentralized science, underscoring the team’s commitment to open data sharing and value reconstruction through blockchain technology.
Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information.
Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.